Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.8M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
6.84M
-
Shares change
-
-1.93M
-
Total reported value, excl. options
-
$51.8M
-
Value change
-
-$13M
-
Put/Call ratio
-
0.58
-
Number of buys
-
22
-
Number of sells
-
-35
-
Price
-
$6.16
Significant Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON) as of Q2 2021
67 filings reported holding ETON - Eton Pharmaceuticals, Inc. - Common Stock as of Q2 2021.
Eton Pharmaceuticals, Inc. - Common Stock (ETON) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.84M shares
of 26.8M outstanding shares and own 25.48% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (3.69M shares), VANGUARD GROUP INC (862K shares), AWM Investment Company, Inc. (500K shares), BlackRock Inc. (301K shares), PRICE T ROWE ASSOCIATES INC /MD/ (218K shares), GEODE CAPITAL MANAGEMENT, LLC (155K shares), MILLENNIUM MANAGEMENT LLC (135K shares), Westside Investment Management, Inc. (102K shares), MARSHALL WACE, LLP (84.9K shares), and STATE STREET CORP (83.8K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.